Cervicovaginal microbiome and natural history of HPV in a longitudinal study
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Costa Rica
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Uterine cervix Canalis cervicis uteri,Caudal segment of uterus,Cervical canal,Cervical canal of uterus,Cervix,Cervix of uterus,Cervix uteri,Neck of uterus,Uterine cervix,uterine cervix
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Human papilloma virus infection HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- HPV (clearance)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Visit 1 HPV (progression)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- HPV progression to CIN2+ lesion diagnosis
- Group 0 sample size Number of subjects in the control (unexposed) group
- 70
- Group 1 sample size Number of subjects in the case (exposed) group
- 33
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Figure 4
Description: Bacteria associated with progression to CIN2+ identified using LEfSe
Abundance in Group 1: increased abundance in Visit 1 HPV (progression)
Signature 2
Source: Figure 4
Description: Bacteria associated with progression to CIN2+ identified using LEfSe
Abundance in Group 1: decreased abundance in Visit 1 HPV (progression)
NCBI | Quality Control | Links |
---|---|---|
Segatella paludivivens | ||
Lactobacillus iners |
Revision editor(s): WikiWorks
Experiment 2
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Visit 2 HPV (progression)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 69
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Figure 4
Description: Bacteria associated with progression to CIN2+ identified using LEfSe
Abundance in Group 1: increased abundance in Visit 2 HPV (progression)
Revision editor(s): WikiWorks
Signature 2
Source: Figure 4
Description: Bacteria associated with progression to CIN2+ identified using LEfSe
Abundance in Group 1: decreased abundance in Visit 2 HPV (progression)
NCBI | Quality Control | Links |
---|---|---|
Actinomyces johnsonii | ||
Atopobium minutum | ||
Acetivibrio clariflavus |